Status:
UNKNOWN
The Efficacy of Botulinum Toxin in Spastic Neuropathic Bladder
Lead Sponsor:
AHMED FARAHAT HASSAN
Conditions:
Spastic Neurogenic Bladder
Eligibility:
All Genders
Brief Summary
To assess the efficacy of botulinum toxin in spastic neurogenic bladder.
Detailed Description
Neurogenic detrusor overactivity (NDO) can result in lower and upper urinary tract complications and eventually even in end-stage kidney failure. Since the driving force of this clinical cascade is hi...
Eligibility Criteria
Inclusion
- 1- patients with spastic neurogenic bladder due to upper motor neuron lesion as (spinal cord lesions ,multiple sclerosis ,strokes,parkinsonism...........).
- 2- patients with spastic neurogenic bladder diagnosed clinically and urodynamically.
Exclusion
- 1-patients with associated lower motor neuron lesions. 2-atonic bladder. 3-patients with diabetes mellitus.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03407183
Start Date
January 1 2018
End Date
March 1 2019
Last Update
January 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Farahat
Asyut, Egypt